Brukinsa Европска Унија - Исландски - EMA (European Medicines Agency)

brukinsa

beigene ireland ltd - zanubrutinib - waldenstrom macroglobulinemia - Æxlishemjandi lyf - brukinsa as monotherapy is indicated for the treatment of adult patients with waldenström’s macroglobulinaemia (wm) who have received at least one prior therapy, or in first line treatment for patients unsuitable for chemo-immunotherapy. brukinsa as monotherapy is indicated for the treatment of adult patients with marginal zone lymphoma (mzl) who have received at least one prior anti-cd20-based therapy. brukinsa as monotherapy is indicated for the treatment of adult patients with chronic lymphocytic leukemia (cll).

Orgovyx Европска Унија - Исландски - EMA (European Medicines Agency)

orgovyx

accord healthcare s.l.u. - relugolix - blöðruhálskirtli - innkirtla meðferð - orgovyx is indicated for the treatment of adult patients with advanced hormone-sensitive prostate cancer.

Quviviq Европска Унија - Исландски - EMA (European Medicines Agency)

quviviq

idorsia pharmaceuticals deutschland gmbh - daridorexant hydrochloride - svefntruflun og viðhald - psycholeptics - quviviq is indicated for the treatment of adult patients with insomnia characterised by symptoms present for at least 3 months and considerable impact on daytime functioning.

Pyrukynd Европска Унија - Исландски - EMA (European Medicines Agency)

pyrukynd

agios netherlands b.v. - mitapivat sulfate - genetic diseases, inborn; anemia, hemolytic - other hematological agents - pyrukynd is indicated for the treatment of pyruvate kinase deficiency (pk deficiency) in adult patients (see section 4.

Microgyn Tafla Исланд - Исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

microgyn tafla

bayer ab* - levonorgestrelum inn; ethinylestradiolum inn - tafla

Navelbine Mjúkt hylki 30 mg Исланд - Исландски - LYFJASTOFNUN (Icelandic Medicines Agency)

navelbine mjúkt hylki 30 mg

pierre fabre pharma norden ab - vinorelbinum tvítartrat - mjúkt hylki - 30 mg